首页 | 本学科首页   官方微博 | 高级检索  
检索        

组织工程化肌腱对T淋巴细胞亚群及其受体的影响
引用本文:曲彦隆,杨志明,解慧琪,朱伟南,雷松.组织工程化肌腱对T淋巴细胞亚群及其受体的影响[J].中国修复重建外科杂志,2001,15(2):113-117.
作者姓名:曲彦隆  杨志明  解慧琪  朱伟南  雷松
作者单位:1. 华西医科大学附属第一医院骨科(成都,610041
2. 流式细胞室
基金项目:国家重点基础研究发展规划(973):组织工程的基本科学问题(G1999054308);国家自然科学基金资助项目(39870202);美国纽约中华医学基金会资助项目(CMB 98-682)
摘    要:目的:探讨组织工程化肌腱对T淋巴细胞亚群及受体的影响。明确其组织相容性,方法:采用3月龄法国罗曼鸡75只,随机分成五组,每组15只,手术造成足第3趾屈深肌腱2.5cm缺损后,分组。A组:未手术组,B组:自体肌腱移植组;C组:新鲜同种异体肌腱移植组;D组:梯度降解材料复合腱细胞移植组;E组、;衍生肌腱材料复合腱细胞移植组,检测CD4+,CD8+,CD28细胞阳性率及T淋巴细胞相关抗原受体(TCR)密度变化,通过刀豆蛋白(ConA)诱导的淋巴细胞转化试验,直接淋巴细胞混合培养试验及间接淋巴细胞混合培养试验,了解机体对肌腱细胞的免疫反应水平。结果:D,E组与B组比较,早期CD4+,CD8+TCR轻度增高,2周后下降,无显著性差异(P>0.05),C组CD4+,CD8+,CD28及TCR阳性率与D,E组比较,有显著性差异(P<0.05),结论:肌腱细胞为弱抗原细胞,抗原脱落或可溶性抗原分泌较少,组织工程化肌腱有良好的组织相容性。

关 键 词:组织工程肌腱  免疫反应  T淋巴细胞亚群  肌腱损伤  修复
修稿时间:2000年10月23

THE INFLUENCE OF TISSUE ENGINEERED TENDON ON SUBGROUP OF T LYMPHOCYTES AND ITS RECEPTOR IN ROMAN CHICKENS
QU Yan-long,YANG Zhi-ming,XIE Hui-qi,et al..THE INFLUENCE OF TISSUE ENGINEERED TENDON ON SUBGROUP OF T LYMPHOCYTES AND ITS RECEPTOR IN ROMAN CHICKENS[J].Chinese Journal of Reparative and Reconstructive Surgery,2001,15(2):113-117.
Authors:QU Yan-long  YANG Zhi-ming  XIE Hui-qi  
Institution:Department of Orthopedic Surgery, First University Hospital, West China University of Medical Sciences, Chengdu Sichuan, P, R, China 610041. orthop@public.cd.sc.cn
Abstract:OBJECTIVE: To investigate the influence of tissue engineered tendon on subgroup of T lymphocytes and its receptor in Roman chickens. METHODS: The flexor digitorum profundus of the third toes of right feet in 75 Roman chickens were resected and made 2.5 cm defects as experimental model. They were randomly divided into five groups according to five repair methods: no operation (group A), autograft (group B), fresh allograft (group C), polymer combined with allogenous tendon cells (group D), derived tendon materials combined with allogenous tendon cells (group E). The proliferation and transformation of lymphocytes and contribution of CD4+, CD8+, CD28 and T cell receptor (TCR) were detected to study the immune response. RESULTS: The CD4+, CD8+ and TCR of group D and E were increased slightly than that of group B after 7 days, while after 14 days, those data decreased gradually and no significant difference between tissue engineered tendon and autografts (P > 0.05), and there was significant difference between fresh allograft and tissue engineered tendon (P < 0.05). Lymphocytes transformation induced by conA also showed no significant difference between tissue engineered tendon and autografts (P > 0.05). CONCLUSION: Tendon cells are hypoantigen cells, there are less secretion of soluble antigen or antigen chips dropped out from cells. Tissue engineered tendon has excellent biocompatibility.
Keywords:Tissue engineering    Tendon    Immune response  Foundation items: National Basic Science Research and Development Grants (G1999054308)  National Natural Science Foundation of China(39870202)  China Medical Board of New York (CMB 98-682)
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号